NCT04776252 · Interventional trial
Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033)
Overall registry status Active not recruiting
Phase 3
Conditions HIV-1 Infection
Delaware Valley sites
- Penn Medicine: University of Pennsylvania Health System-Perelman Center for Advanced Medicine ( Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory